ME00578A - Use of gastrointestinal lipase inhibitors - Google Patents

Use of gastrointestinal lipase inhibitors

Info

Publication number
ME00578A
ME00578A MEP-903/08A MEP90308A ME00578A ME 00578 A ME00578 A ME 00578A ME P90308 A MEP90308 A ME P90308A ME 00578 A ME00578 A ME 00578A
Authority
ME
Montenegro
Prior art keywords
lipase inhibitors
gastrointestinal lipase
gastrointestinal
inhibitors
medicaments
Prior art date
Application number
MEP-903/08A
Other languages
English (en)
Croatian (hr)
Inventor
Jonathan Brian Hauptman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21894047&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME00578(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of ME00578A publication Critical patent/ME00578A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
MEP-903/08A 1997-02-05 1998-01-29 Use of gastrointestinal lipase inhibitors ME00578A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3738397P 1997-02-05 1997-02-05
PCT/EP1998/000468 WO1998034630A1 (en) 1997-02-05 1998-01-29 Use of gastrointestinal lipase inhibitors

Publications (1)

Publication Number Publication Date
ME00578A true ME00578A (en) 2011-12-20

Family

ID=21894047

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-903/08A ME00578A (en) 1997-02-05 1998-01-29 Use of gastrointestinal lipase inhibitors

Country Status (27)

Country Link
US (1) US6147108A (cs)
EP (1) EP1017408B1 (cs)
JP (1) JP2001509173A (cs)
KR (1) KR100479968B1 (cs)
CN (1) CN1154505C (cs)
AR (1) AR011106A1 (cs)
AT (1) ATE292975T1 (cs)
AU (1) AU740375B2 (cs)
BR (1) BR9807655A (cs)
CA (1) CA2278854C (cs)
CZ (1) CZ295567B6 (cs)
DE (1) DE69829763T2 (cs)
DK (1) DK1017408T3 (cs)
ES (1) ES2239799T3 (cs)
HU (1) HU230834B1 (cs)
ID (1) ID22650A (cs)
IL (1) IL131007A0 (cs)
ME (1) ME00578A (cs)
NO (1) NO324452B1 (cs)
NZ (1) NZ336755A (cs)
PL (1) PL191222B1 (cs)
PT (1) PT1017408E (cs)
RU (1) RU2201272C2 (cs)
TR (1) TR199901853T2 (cs)
WO (1) WO1998034630A1 (cs)
YU (1) YU34199A (cs)
ZA (1) ZA98753B (cs)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU740375B2 (en) * 1997-02-05 2001-11-01 F. Hoffmann-La Roche Ag Use of gastrointestinal lipase inhibitors
AR025587A1 (es) * 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones en dispersion que contienen inhibidores de lipasa
AR025609A1 (es) 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones lipidas solidas
DE60138333D1 (de) 2000-03-14 2009-05-28 Unilever Nv Variabele Domänen der schweren Kette eines Antikörpers gegen menschliche Ernährungslipasen und deren Verwendungen
US6867183B2 (en) 2001-02-15 2005-03-15 Nobex Corporation Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US7060675B2 (en) 2001-02-15 2006-06-13 Nobex Corporation Methods of treating diabetes mellitus
US6828297B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7196059B2 (en) 2001-09-07 2007-03-27 Biocon Limited Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
WO2003105768A2 (en) 2002-06-13 2003-12-24 Nobex Corporation Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
US9174176B2 (en) 2003-01-09 2015-11-03 Disperse Systems, Inc. Ultrasonic dispersion apparatus, system, and method
RU2248793C1 (ru) * 2003-11-13 2005-03-27 Лазебник Леонид Борисович Способ лечения стеатогепатитов
US7510849B2 (en) * 2004-01-29 2009-03-31 Glucolight Corporation OCT based method for diagnosis and therapy
PL2626368T3 (pl) 2004-07-19 2017-06-30 Biocon Limited Koniugaty insulina-oligomer, ich formulacje i zastosowania
US8036727B2 (en) * 2004-08-11 2011-10-11 Glt Acquisition Corp. Methods for noninvasively measuring analyte levels in a subject
US7254429B2 (en) 2004-08-11 2007-08-07 Glucolight Corporation Method and apparatus for monitoring glucose levels in a biological tissue
WO2006110859A2 (en) 2005-04-13 2006-10-19 Glucolight Corporation Method for data reduction and calibration of an oct-based blood glucose monitor
US8217025B2 (en) * 2006-11-17 2012-07-10 Harbor Therapeutics, Inc. Drug screening and treatment methods
DE602007008567D1 (de) * 2007-09-12 2010-09-30 Mader S R L Pharmazeutische Zusammensetzungen zur oralen Verabreichung bei der Behandlung von Adipositas-Patienten
MX2010004072A (es) * 2007-10-15 2010-09-14 Inventis Dds Pvt Ltd Composicion farmaceutica de orlistat.
ES2664822T3 (es) 2007-10-16 2018-04-23 Biocon Limited Una composición farmacéutica sólida administrable por vía oral y un proceso de la misma
US8571617B2 (en) 2008-03-04 2013-10-29 Glt Acquisition Corp. Flowometry in optical coherence tomography for analyte level estimation
WO2010042499A1 (en) * 2008-10-06 2010-04-15 Banner Pharmacaps, Inc. Stable solutions of orlistat for pharmaceutical dosage forms
FR3017536B1 (fr) * 2014-02-18 2017-05-26 Univ La Rochelle Compositions pour la prevention et/ou le traitement de pathologies liees a l'alpha-glucosidase
WO2017161043A1 (en) * 2016-03-16 2017-09-21 The J. David Gladstone Institutes Methods and compositions for treating obesity and/or diabetes and for identifying candidate treatment agents
WO2019018849A1 (en) * 2017-07-21 2019-01-24 Kieu Hoang STATINES (ATORVASTATIN) THAT CAN REDUCE GLYCEMIA LEVEL IN DIABETICS

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
CA1328881C (en) * 1984-12-21 1994-04-26 Pierre Barbier Process for the manufacture of oxetanones
CA1270837A (en) * 1984-12-21 1990-06-26 Hoffmann-La Roche Limited Oxetanones
CA2035972C (en) * 1990-02-23 2006-07-11 Martin Karpf Process for the preparation of oxetanones
US5298497A (en) * 1990-05-15 1994-03-29 E. R. Squibb & Sons, Inc. Method for preventing onset of hypertension employing a cholesterol lowering drug
US5190970A (en) * 1990-10-19 1993-03-02 E. R. Squibb & Sons, Inc. Method for preventing onset of or treating Type II diabetes employing a cholesterol lowering drug alone or in combination with an ace inhibitor
US5130333A (en) * 1990-10-19 1992-07-14 E. R. Squibb & Sons, Inc. Method for treating type II diabetes employing a cholesterol lowering drug
US5345056A (en) * 1991-12-12 1994-09-06 Motorola, Inc. Plasma based soldering by indirect heating
CA2098167C (en) * 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
TW381025B (en) * 1993-08-05 2000-02-01 Hoffmann La Roche Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor
JP3532999B2 (ja) * 1995-03-24 2004-05-31 株式会社ロッテ 新規なタンニン類およびこれを有効成分とするリパーゼ阻害剤
JPH09227398A (ja) * 1996-02-20 1997-09-02 Zeria Pharmaceut Co Ltd 抗肥満剤
AU740375B2 (en) * 1997-02-05 2001-11-01 F. Hoffmann-La Roche Ag Use of gastrointestinal lipase inhibitors
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions

Also Published As

Publication number Publication date
JP2001509173A (ja) 2001-07-10
KR20000070733A (ko) 2000-11-25
CA2278854C (en) 2014-03-04
HUP0001014A2 (hu) 2000-08-28
PT1017408E (pt) 2005-07-29
DE69829763D1 (de) 2005-05-19
CA2278854A1 (en) 1998-08-13
DK1017408T3 (da) 2005-08-01
AU740375B2 (en) 2001-11-01
CZ265199A3 (cs) 2000-02-16
ZA98753B (en) 1998-08-05
IL131007A0 (en) 2001-01-28
NO993717D0 (no) 1999-07-30
RU2201272C2 (ru) 2003-03-27
HK1025251A1 (en) 2000-11-10
YU34199A (sh) 2002-08-12
PL191222B1 (pl) 2006-03-31
ATE292975T1 (de) 2005-04-15
HU230834B1 (hu) 2018-07-30
CN1246798A (zh) 2000-03-08
EP1017408A1 (en) 2000-07-12
DE69829763T2 (de) 2006-04-13
ID22650A (id) 1999-12-02
PL334975A1 (en) 2000-03-27
AR011106A1 (es) 2000-08-02
TR199901853T2 (xx) 1999-12-21
CZ295567B6 (cs) 2005-08-17
NZ336755A (en) 2001-06-29
AU6616998A (en) 1998-08-26
BR9807655A (pt) 2000-02-15
CN1154505C (zh) 2004-06-23
WO1998034630A1 (en) 1998-08-13
KR100479968B1 (ko) 2005-03-30
HUP0001014A3 (en) 2000-12-28
NO993717L (no) 1999-10-04
US6147108A (en) 2000-11-14
NO324452B1 (no) 2007-10-22
EP1017408B1 (en) 2005-04-13
ES2239799T3 (es) 2005-10-01

Similar Documents

Publication Publication Date Title
ME00578A (en) Use of gastrointestinal lipase inhibitors
NO992907D0 (no) Flat legemiddeltilberedning for applikasjon og frigiving av buprenorfin eller et annet farmakologisk sammenlignbart stoff i munnhulen og fremgangsmÕte for dens fremstilling
DE60121988D1 (de) Kombinationstherapie mit antidiabetischen und antikonvulsiven mitteln
EE200300212A (et) Ravimite kombinatsioonid (näiteks kloorpromasiin ja pentamidiin) neoplastiliste haiguste raviks
NO20006630D0 (no) Farmasöytisk sammensetning for behandlingen av diabetes
RS50091B (sr) Upotreba retigabina u lečenju neuropatskog bola
NL300258I1 (nl) Farmaceutische samenstelling voor toepassing in debehandeling van diabetes.
NO20020770D0 (no) Anvendelse av monoaminoksidaseinhibitorer for fremstilling av legemidler egnet for behandling av fedme
WO2003080582A3 (de) Fredericamycin-derivate
AU2386201A (en) Substituted sapogenins and their use
DK0758241T3 (da) Anvendelse af visse methanbisphosphonsyrederivater til at hindre løsning og vandring af proteser
ATE400577T1 (de) Anellierte dihydropyrane
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
EP1295609A4 (en) MEDICINES WITH MIXED ACTIVE SUBSTANCES
AU2855399A (en) Vascularization inhibitors
DE69531098D1 (de) Piperidine und pyrrolidine
DE59813162D1 (de) Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
DE69633396D1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
EE9900450A (et) Tetrahüdropüridoühendid, neid sisaldav ravim ja nende kasutamine
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
HUP9802423A2 (hu) Hiperproliferatív megbetegedések kombinált gyógyászati kezelése
DE60202590D1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
NO20014081L (no) Anvendelse av tianeptin i produksjonen av medikamenter til behandling av nevrodegenerative patologier
NO20020914D0 (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav